Nectar Lifesciences Limited

Nectar Lifesciences board meeting scheduled for November 14, 2026 to approve Q2 FY2027 unaudited financial results. Disclosure made pursuant to SEBI LODR Regulations 29, 30, and 33 for regulatory comp